![]() ![]() Create or support internal NPV models to improve accuracy.Better understand the quantitative value of a specific drug.Combining these data points with GlobalData’s world class analysis creates high value models that companies can use to help in evaluation processes for each drug or company. GlobalData takes into account factors including patent law, known and projected regulatory approval processes, cash flows, potential applicable patients, drug margins, company expenses, and pricing estimates. It was also under development for the treatment of metastatic castration-resistant (hormone-refractory) prostate cancer and metastatic HER2 negative hormone receptor-positive breast cancer patients with bone metastases and multiple myeloma. ![]() It is indicated for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease.Radium-223 chloride is under development for the treatment of castration resistant prostate cancer (CRPC) with bone metastasis, non-small cell lung cancer (NSCLC) with bone metastases, metastatic renal cell carcinoma and metastatic osteosarcoma. Radium-223 chloride (Xofigo) is an antineoplastic agent, It is formulated as solution for intravenous route of administration. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. ![]() Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |